Non-small cell lung cancer (NSCLC) is diagnosed at an early stage, when it is amenable to surgical resection in approximately 20% to 25% of cases.
Seema Harichand-Herdt, MD
Advertisement
Articles by Seema Harichand-Herdt, MD
Advertisement
Latest Updated Articles
- Adjuvant Therapy for Non-Small Cell Lung Cancer: Impact of Recent Clinical Trials on Community Practice
Published: March 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA
2
CGTLive®’s Weekly Rewind – December 19, 2025
3
The Implications of the Final Data From Hemgenix’s HOPE-B Trial
4
Around the Helix: Cell and Gene Therapy Company Updates – December 17, 2025
5